For the year ending 2025-12-31, LXRX made $49,803K in revenue. -$50,430K in net income. Net profit margin of -101.26%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 49,803 | 31,081 | ||
| Cost of sales | 274 | 616 | ||
| Research and development | 61,121 | 84,480 | ||
| Selling, general and administrative expense | 37,319 | 143,102 | ||
| Total operating expenses | 98,714 | 228,198 | ||
| Loss from operations | -48,911 | -197,117 | ||
| Interest and other expense | 8,339 | 15,579 | ||
| Interest income and other | 6,909 | 12,293 | ||
| Net loss | -50,341 | -200,403 | ||
| Unrealized (loss) gain on investments | -89 | 88 | ||
| Comprehensive loss | -50,430 | -200,315 | ||
| Basic EPS | -0.14 | -0.63 | ||
| Diluted EPS | -0.14 | -0.63 | ||
| Basic Average Shares | 363,053,000 | 320,031,000 | ||
| Diluted Average Shares | 363,053,000 | 320,031,000 | ||
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)